Clinical Lead of the Psilocybin for Depression trial at Imperial College London
But don't take our word for it...
Below are links, citations, lectures, and quotes to some impressive research.
Research says psilocybin is safe and effective.
"Although many of us think of psychedelics as dangerous drugs, it’s time for a rethink. They are non-toxic, non-addictive, have very few side effects, and could potentially offer relief for people suffering from a range of psychological difficulties."
—Dr. Rosalind Watts, PhD.
Psilocybin, love and the meaning of life
Johns Hopkins Researcher Mary Cosimano shares promising results from clinical trials of guided psilocybin sessions being utilized in the treatment of addiction, depression, and cancer/end-of-life. The impressive results offer much hope for an effective treatment to heal “hearts and minds.” One of Mary’s key observations is the importance of love and connection — it seems, love is literally part of the answer.
“It is no surprise that psychedelics, with their activation of deeply healing intelligent capacities, seem to spontaneously engender internal and interpersonal experiences of love.”
—Adele Lafrance, PhD.
Clinical psychologist, research scientist, best-selling author and speaker. A leader in psychedelic medicine research
FREE TRAINING WEBINAR
VA Studying Psychedelics As Mental Health Treatment For Veterans
In New York, researchers are testing MDMA-assisted psychotherapy for a group of veterans in a trial that has already been in testing for a year. Three additional trials of MDMA and synthetic psilocybin, the active compound in psychedelic mushrooms, are scheduled to begin later this year at clinics in Portland and San Diego. Dr. Leslie Morland, a clinical psychologist at the Veterans Affairs Healthcare System in San Diego, is researching the potential for MDMA to enhance couples therapy in relationships challenged by PTSD.
Is psilocybin safe?
A thorough survey found that magic mushrooms appear to be the safest drug.
*More than 120,000 participants in 50 countries participated in this study.
The science of psilocybin and its use to relieve suffering
Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.
Universities:
309
There are at least 309 major Universities worldwide actively researching psychedelics including psilocybin, which is the most researched of all psychedelic medications.
Clinical Trials:
628
Clinical trials have assessed the feasibility, safety, and efficacy of psilocybin on persons with treatment-resistant mental wellness disorders.
Published Studies:
27,000
To date, over 27,000 scientific articles have been published on psychedelic drugs, with over 1,000 particularly on psilocybin. Currently, psilocybin is the most studied psychedelic medication.
Here are just a few of the 309 Universities researching Psilocybin and other psychedelics
17 Clinical Trials
8 Clinical Trials
17 Clinical Trials
11 Clinical Trials
28 Clinical Trials
11 Clinical Trials
10 Clinical Trials
18 Clinical Trials
Can Magic Mushrooms Unlock Depression?
Clinical psychologist from Imperial College describes how Magic Mushrooms (Psilocybin), when used in a therapeutic setting, have been found to be a very effective treatment for depression. In this talk she draws on her experiences as working as a therapist on the groundbreaking Psilocybin for Depression study, and introduces us to some of the patients and their stories of transformation.
Here's 3 some quick summaries
.....and it's all good news
arrow_drop_down_circle
Divider Text
Psychedelic Drug Psilocybin Tamps Down Brain’s Ego Center
The brain scans after psilocybin use showed that the claustrum was less active, meaning the area of the brain believed responsible for setting attention and switching tasks is turned down when on the drug. The researchers say that this ties in with what people report as typical effects of psychedelic drugs, including feelings of being connected to everything and reduced senses of self or ego.
Psychedelic Treatment with Psilocybin Relieves Major Depression, Study Show
In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up.
First Federal Grant for Psychedelic Treatment Research in 50 years
Johns Hopkins Medicine was awarded a grant from the National Institutes of Health (NIH) to explore the potential impacts of psilocybin on tobacco addiction. This is the first NIH grant awarded in over a half century to directly investigate the therapeutic effects of a classic psychedelic, consistent with a recent study published online that searched NIH funding and found zero grants were awarded between 2006 and 2020.
Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows
Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.
"There is a wealth of information built into us...tucked away in the genetic materal in every one of our cells....without some means of access, there is no way even to begin to guess at the extent and quality of what is there. The psychedelic drugs allow exploration of this interior world, and insights into its nature"
—Alexander Shulgin PhD.
Numerous DEA Awards numerous for Chemistry, psychology, philosophy, & biology
The Neuroscience of Psychedelic Drugs, Music and Nostalgia
YouTube description:
With controlled psychedelic substances, there is a potential to alter the entire brain for a period of time and thus provide relief from negative emotions that cloud the mind. Capturing this controlled relief, Dr Frederick Barrett's research suggests that, under the right conditions, psychedelics may have the potential to treat a wide range of mood and substance disorders.
Some Primary Research to Check Out:
- Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Journal of Psychopharmacology. 2019;33(9):1088-1101. doi:10.1177/0269881119845793
- Hendricks PS, Crawford MS, Cropsey KL, Copes H, Sweat NW, Walsh Z, Pavela G. The relationships of classic psychedelic use with criminal behavior in the United States adult population. J Psychopharmacol. 2018 Jan;32(1):37-48. doi: 10.1177/0269881117735685. Epub 2017 Oct 17. PMID: 29039233.
- Jones GM, Nock MK. Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension. J Psychopharmacol. 2022 Jan;36(1):66-73. doi: 10.1177/02698811211058933. PMID: 35090364
Copyright © 2023